Provider

By Bill Siwicki October 20, 2017
Health IT company Wellbe is expanding its online patient navigation and engagement platform by partnering with Physiotec and Staywell. Physiotec delivers online rehabilitation programs and Staywell delivers a comprehensive library of guidelines-based content. In the face of the converging forces of consumerism and value-based care, hospitals are seeking to enable robust patient participation in...
By Jonah Comstock October 20, 2017
In the third quarter of 2017, we saw a lot of news from hospitals launching new digital health initiatives. Many hospitals and health systems partnered with digital health startups for pilots or full deployments, and a few launched their own offerings developed in house. Large health systems also participated in research activities to validate digital health technologies. Read on for a round-up...
By MobiHealthNews October 20, 2017
Led by a new commissioner in Dr. Scott Gottlieb, the FDA had a busy few months with a handful of digital and mobile technologies getting cleared in the third quarter of 2017. Consumer-focused diabetes and pain management offerings were prominent, but but by and large the clearances hit a multitude of clinical concerns and, of note, even included the first software-only digital therapeutic....
By Mike Miliard October 19, 2017
Genomic sequencing has come a long way in a short time, and its potential to drive even faster innovations in precision medicine is enormous. To capitalize on that opportunity, however, health systems need data – lots of it, from all sorts of people. Kaiser Permanente has been building a biobank with genomic data and other health information from hundreds of thousands of patients from across its...
By Jonah Comstock October 19, 2017
The Thrive Innovation Center in Louisville, Kentucky opened today. The Center is a nonprofit dedicated to showcasing new aging in place technologies in partnership with tech companies like Samsung, CDW Healthcare, Lenovo, and Aruba, as well as a number of aging tech startups. "We really wanted to create a center that was more of an experiential center, not a tradeshow floor," CEO and Executive...
By Dave Muoio October 19, 2017
A multidisciplinary group of researchers have detailed a novel infectious disease diagnostic platform that relies on the user’s smartphone to provide point-of-care screening. Housed within a portable 3D-printed cradle, the tool uses the smartphone and an app to interpret real-time images of a microfluidic chip embedded on credit card-like cartridge. Researchers say it's the only point-of-care...
By Dave Muoio October 19, 2017
Argentinian ambulance doctors are using WhatsApp to fasttrack their patients’ care. Study data presented at the Argentine Congress of Cardiology’s 2017 conference suggests that using the free messaging app to send diagnostic electrocardiograms (ECGs) directly to a hospital’s catheterization lab allowed heart attack patients to bypass the emergency department and reduce mortality. “We found that...
By Dave Muoio October 18, 2017
Efforts to build artificial pancreas (AP) systems under open protocols will get a boost from JDRF, a multinational group that funds Type 1 diabetes research and other programs. The organization has announced a new initiative to not only provide funds for these DIY and frequently reverse engineered projects, but will also provide the regulatory and liability guidance necessary for a public release...
By Dave Muoio October 18, 2017
As telehealth becomes more prevalent among US healthcare institutions, states are rolling out or modifying their laws to better define regulatory frameworks specifically affecting remote delivery of care. In fact, every state but Connecticut and Massachusetts has made substantive legal changes to how telehealth is delivered in the past year, with some taking specific actions to better define the...
By Jonah Comstock October 18, 2017
Pear Therapeutics announced today that reSET-O, a digital therapeutic for opioid use disorder, has received an Expedited Access Pathway (EAP) designation from the FDA. The EAP designation doesn't mean that the FDA has cleared the product, only that it has committed to fast-tracking it through the clearance process because of its timely public health value.  “The opioid epidemic continues to...